On February 24, 2020 Silverback Therapeutics, Inc., a biopharmaceutical company developing a pipeline of systemically delivered, locally active therapies, reported Peter Thompson, M.D., co-founder, president and chief executive officer, will present corporate updates at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020, at 1:45 pm ET at the Lotte New York Palace Hotel (Press release, Silverback Therapeutics, FEB 24, 2020, View Source [SID1234554670]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be accessible on the company’s website and a replay of the webcast will be archived on the company’s website for 90 days.